Results 61 to 70 of about 1,139 (118)

Training needs and curricular priorities for managing multimorbidity in Spanish primary care: findings from a national exploratory online survey. [PDF]

BMC Prim Care
Leiva-Fernández F, González-Hevilla A, Castillo-Jimena M, Moreno-Juste A, López-Rodríguez JA, Ara-Bardají P, Del Cura-González I, Gimeno-Miguel A, MULTIPAP Group.   +8 more
europepmc   +1 more source

Adverse events as key risk factors for in-hospital mortality in intensive care units. [PDF]

Crit Care
Roncal-Redín M, San Jose-Saras D, Díaz-Agero Pérez C, Vicente-Guijarro J, Moreno-Nunez P, Peñalver-Argüeso B, Aranaz-Andres JM, ESHMAD director group, external advisers.   +8 more
europepmc   +1 more source

Pleural effusion as a mortality predictor for acute pulmonary embolism. [PDF]

Res Pract Thromb Haemost
Jiménez D, Yusen RD, Jara I, Galeano-Valle F, Demelo-Rodríguez P, Ruiz-Artacho P, Barillari G, Gavín-Sebastián O, Bikdeli B, Monreal M, RIETE Investigators.   +10 more
europepmc   +1 more source

Trends in the prevalence of bloodstream infections in Spanish hospitals (2013-2023). [PDF]

Antimicrob Resist Infect Control
Parra LM, Escuredo R, Cantero M, Gonzalez-Perez ME, García de la Vega M, Asensio Á, EPINE Study Group.   +6 more
europepmc   +1 more source

Upper Extremity Deep Vein Thrombosis in Cancer Patients: Clinical Course by Cancer Site. [PDF]

JACC CardioOncol
Espitia O, Guedon AF, Courouve E, Brenner B, López-Núñez JJ, Chopard R, Lorenzo A, Sigüenza P, Truong Nguyen S, Monreal M, RIETE Investigators.   +10 more
europepmc   +1 more source

Attributable mortality to healthcare-associated infections: a comprehensive nationwide assessment in Spain, 2022 and 2023. [PDF]

Euro Surveill
Cantero M, Salamanca C, Parra LM, González-Pérez ME, García de la Vega M, Asensio Á, EPINE Study Group.   +6 more
europepmc   +1 more source

Effect of Non-nucleoside Resistance-Associated Mutations on the Effectiveness of Long-Acting Cabotegravir + Rilpivirine Therapy: Insights From the Real-World RELATIVITY Cohort. [PDF]

Open Forum Infect Dis
Rial-Crestelo D, Llenas-García J, Hidalgo-Tenorio C, Troya García J, Galindo Puerto MJ, Alemán Valls MR, Torralba González de Suso M, Buzón L, Díaz de Santiago A, Rodríguez A, Calzado Isbert S, Aguilera García M, Morano Amado LE, Vinuesa García D, Bernal Morell E, Martínez Álvarez RM, Cabello-Clotet N, Fernández A, Montero Hernández MDC, Díez Romero C, Calderón Hernaiz R, Pérez Martínez D, Gisbert Pérez L, Arenas García V, Escrich C, Fariñas Álvarez MC, Lucas Dato A, Losa García JE, Pernas Pardavila H, Gainzarain JC, Estébanez M, Barragán Gallo P, Clavero Olmos M, Egido Murciano MV, Benéitez OLF, Pedrero-Tomé R, Cabello-Úbeda A, Martín-Carbonero L, RELATIVITY studygroup.   +38 more
europepmc   +1 more source

Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database. [PDF]

Eye (Lond)
Zarranz-Ventura J, Garay-Aramburu G, Calvo P, Zapata MA, Arruabarrena C, Arnáiz P, García-Lunar P, Sararols-Ramsay L, FRB SPAIN study group.   +8 more
europepmc   +1 more source

20885. TRATAMIENTO DE REPERFUSIÓN EN EL ICTUS POR OCLUSIÓN DISTAL DE ARTERIA CEREBRAL MEDIA: TROMBECTOMÍA VS. TROMBOLISIS IV

Neurology Perspectives
C. Sánchez Rodríguez, A. Lorenzo Montilla, A. Cruz-Culebras, C. Gómez Escalonilla, C. Hervás, F. Díaz Otero, R. Vera, M. Moreu, R. Rigual, A. García Pastor, J. Vega, C. Alonso, R. Berbegal, S. Trillo   +13 more
doaj   +1 more source

New integrated three-interface conceptual model for clearance and immune surveillance in the human CNS. [PDF]

Front Cell Dev Biol
García-Cosamalón J, Marchena M, Villar-Suárez V, Ley L, de Castro F.   +4 more
europepmc   +1 more source